Crucell, the vaccines arm of Johnson & Johnson ($JNJ), suspended a delivery of 2.36 million seasonal flu vaccine doses to Italy, Reuters reports. The company stopped the planned supply of its Inflexal V vaccine after two of 32 lots failed quality checks. Report